Nevertheless, these preliminary results in mice may be of great importance to patients battling a neurological disease, such as Alzheimer's disease. This review, in particular, warrants further investigation into the potential therapeutic benefits and implications of ghrelin as a neurocognitive agent. Here, GHRL is linked to early-onset autosomal dominant Alzheimer disease.